{
    "code": "52027011",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027011",
    "time": "2020-11-06 07:46:17",
    "許可證字號": "衛部藥輸字第027011號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/12\/07",
    "發證日期": "105\/12\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202701102",
    "中文品名": "美加柔持續性藥效膜衣錠50毫克",
    "英文品名": "Megazon Prolonged-Release Tablets 50mg",
    "適應症": "治療思覺失調症、雙極性疾患的鬱症發作、躁症發作或混合發作。對於抗鬱劑單一藥物治療效果不佳的重鬱症（MDD）病人，可作為重鬱症發作的附加治療。開始治療之前，臨床醫師應該考慮Quetiapine XR的安全性。",
    "劑型": "164持續性藥效膜衣錠",
    "包裝": "2-1000錠PVC\/PCTFE\/Alu鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "QUETIAPINE FUMARATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "620110S434  西海生技股份有限公司",
    "申請商地址": "臺北市中山區民權東路二段46號10樓之2",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0044000  PHARMATHEN INTERNATIONAL S.A.",
            "製造廠廠址": "INDUSTRIAL PARK, 5TH BLOCK, 69300, SAPES, RODOPI, GREECE",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200037620",
            "成分名稱": "QUETIAPINE FUMARATE",
            "含量描述": "(equivalent to Quetiapine.....50mg)",
            "含量": "57.5600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020270110004_MEGAZON PRT 50mg_tab_Dec 2016-106-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027011&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "04. 附件四_美加柔持續性藥效膜衣錠50毫克(50+150+200+300mg合併仿單)_仿單電子檔-109-09-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027011&Seq=003&Type=9"
        },
        {
            "title": "020270110003_MEGAZON PRT 50mg_outer_Dec 2016-106-01-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027011&Seq=002&Type=8"
        }
    ]
}